key: cord-0969990-iiic8fig
authors: Chen, Lin-Lei; Chu, Allen Wing-Ho; Zhang, Ricky Rui-Qi; Hung, Ivan Fan-Ngai; To, Kelvin Kai-Wang
title: Serum neutralisation of the SARS-CoV-2 omicron sublineage BA.2
date: 2022-03-28
journal: Lancet Microbe
DOI: 10.1016/s2666-5247(22)00060-x
sha: 29637d709ebec98611d87056cd4d8f92aeb9e79f
doc_id: 969990
cord_uid: iiic8fig

nan

Serum specimens in the 3-dose vaccinated group were collected in our previous prospective cohort study which enrolled SARS-CoV-2 naïve individuals in Hong Kong 1 genome sequence of the culture isolates was determined using nanopore sequencing (Oxford Nanopore Technologies).

Live virus neutralizing antibody (NAb) assay was performed as we described previously [3] [4] [5] 

We did statistical analysis using PRISM 9.3.1. Neutralization antibody titers against BA.2 and BA.2 were compared using Wilcoxon matched-pairs signed rank test. The fold-change between different groups were compared using Kruskal-Wallis test with Dunn's multiple comparisons test. A P value of less than 0.05 was judged statistically significant.

Antibody Response of Combination of BNT162b2 and

CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant

Boosting of Serum Neutralizing Activity Against the Omicron Variant Among Recovered COVID-19 Patients by BNT162b2 and Coronavac Vaccines

Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients

Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study